Biocom’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Private Equity Partner, Orbimed
Chau Quang Khuong is Partner in the Private Equity group at OrbiMed Advisors, a global healthcare-dedicated investment firm with approximately $15 billion in assets under management.
During his career, Mr. Khuong has been an active investor in innovative drug development and medical device enterprises across all stages and therapeutic areas including oncology, infectious diseases, and ophthalmology.
He currently serves as a Board director of numerous public and private companies, including Aerpio Therapeutics, Inc., Cerapedics, Greybug, Immatics, Inspire Medical Systems, Nabriva (NASDAQ: NBVR), NextCure, Otonomy, Inc. (NASDAQ: OTIC), Pieris Pharmaceuticals (NASDAQ: PIRS), ReViral Ltd, and Synlogic.
He holds a B.S. in molecular, cellular and developmental biology with concentration in biotechnology and an MPH with concentration in infectious diseases, both from Yale University.